147 related articles for article (PubMed ID: 27776282)
1. Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy.
Liu J; Zhao D; He W; Zhang H; Li Z; Luan Y
J Colloid Interface Sci; 2017 Feb; 487():239-249. PubMed ID: 27776282
[TBL] [Abstract][Full Text] [Related]
2. Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia.
Fang Z; Wang X; Sun Y; Fan R; Liu Z; Guo R; Xie D
Nanoscale; 2019 Dec; 11(47):23000-23012. PubMed ID: 31769777
[TBL] [Abstract][Full Text] [Related]
3. Spiral assembly of amphiphilic cytarabine prodrug assisted by probe sonication: Enhanced therapy index for leukemia.
Liu J; Ma N; Zhao D; Li Z; Luan Y
Colloids Surf B Biointerfaces; 2015 Dec; 136():918-27. PubMed ID: 26551869
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
5. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy.
Chen H; Li S; Li B; Ren X; Li S; Mahounga DM; Cui S; Gu Y; Achilefu S
Nanoscale; 2012 Sep; 4(19):6050-64. PubMed ID: 22930451
[TBL] [Abstract][Full Text] [Related]
6. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
7. Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery.
Wei W; He Z; Yang J; Sun M; Sun J
Drug Deliv Transl Res; 2018 Oct; 8(5):1162-1170. PubMed ID: 29748833
[TBL] [Abstract][Full Text] [Related]
8. A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors.
Liu R; Jiang Y; Hu X; Wu J; Jiang W; Jin G; Luan Y
Int J Pharm; 2018 Dec; 552(1-2):111-118. PubMed ID: 30268848
[TBL] [Abstract][Full Text] [Related]
9. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
10. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
11. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
12. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
[TBL] [Abstract][Full Text] [Related]
13. Engineered borate ester conjugated protein-polymer nanoconjugates for pH-responsive drug delivery.
Zhou P; Wu S; Hegazy M; Li H; Xu X; Lu H; Huang X
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109914. PubMed ID: 31500030
[TBL] [Abstract][Full Text] [Related]
14. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
15. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
17. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment.
Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T
Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133
[TBL] [Abstract][Full Text] [Related]
18. Graphene oxide-incorporated pH-responsive folate-albumin-photosensitizer nanocomplex as image-guided dual therapeutics.
Battogtokh G; Ko YT
J Control Release; 2016 Jul; 234():10-20. PubMed ID: 27164545
[TBL] [Abstract][Full Text] [Related]
19. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.
Lu JY; Lowe DA; Kennedy MD; Low PS
J Drug Target; 1999; 7(1):43-53. PubMed ID: 10614814
[TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
